Simplifying to Speed up Time to Patient
¡°We¡¯re thinking about a modular way of working, so if the technology develops very fast, we should be able to harness its potential quickly.¡±
What role can IT play in untangling increased trial complexity? ³Ô¹Ï±¬ÁÏ¡¯s Stephan Ohnmacht and Thomas Dieffenbronn (global head of strategy, insights, and technology for global clinical operations at Novartis) discuss how technology strategy in life sciences should strike a balance between quick fixes and innovation, and why simplicity holds the key to speeding up.
Contact the ³Ô¹Ï±¬ÁÏ Business Consulting team to learn more about realizing the value of your technology investments.
